Danish drug-maker Novo Nordisk says its anti-obesity treatment liraglutide could become available for sale in the U.S. by the end of 2014. More
-
-
Sponsored By:
-
Sponsored By:
Hot Stocks
(RSS)
Report: Google Faces New Antitrust Probe Over Ads
The Federal Trade Commission is reportedly in the early stages of a new antitrust investigation over Google's online ad sales practices. More
Google Joins FB in Waze-Buyout Buzz
Internet search giant Google is mulling a possible bid for map app maker Waze, setting up a potential bidding contest with Facebook. More
Procter & Gamble Brings Back ‘Consumer Is Boss’ CEO
A.G. Lafley will become the CEO of Procter & Gamble again in July, replacing out-going CEO Bob McDonald, who replaced him in 2009. More
Gold Jumps as U.S. Dollar, Equities Slip
Gold climbed in Thursday trading as global equities markets declined and the U.S. dollar struggled against other currencies. More
Stocks Shaky Amid China PMI Hit — Thursday’s IP Market Recap
A report from China showing a slowdown in manufacturing shook American indices hard Thursday morning, though much of the market had partly recovered by day's end. More
4 Questionable Hedge Fund Picks From Q1
The nation's biggest hedge funds disclosed their first-quarter buys and sells, with some reminding us that even the pros can sometimes choose poorly. More
